State of Wisconsin Investment Board’s Ra Pharmaceuticals, Inc. Common Stock RARX Stock Holding History

State of Wisconsin Investment Board’s Portfolio RARX Stock Details RARX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-259,994	Closed	-$12.5M	–	1844
2020 Q1	$12.5M	Buy	259,994 +185,594	+249%	+$8.63M	0.04%	435
2019 Q4	$3.49M	Buy	74,400 +27,500	+59%	+$1.22M	0.01%	1033
2019 Q3	$1.11M	Buy	46,900 +19,500	+71%	+$578K	﹤0.01%	1114
2019 Q2	$824K	Buy	27,400 +7,900	+41%	+$181K	﹤0.01%	1187
2019 Q1	$437K	Buy	19,500 +4,400	+29%	+$94.6K	﹤0.01%	1380
2018 Q4	$275K	Buy	+15,100	New	+$237K	﹤0.01%	1422

Other funds holding RARX

Daiwa Securities Group Tokyo, Japan $51.1B AUM 35.55% 1-Year Est. Return

State of Wisconsin Investment Board's RARX Position: Q2 2020 in Review

State of Wisconsin Investment Board sold out of Ra Pharmaceuticals, Inc. Common Stock (RARX) in Q2 2020, closing a stake of 259,994 shares — an estimated $12.5M sold.

State of Wisconsin Investment Board first reported a position in RARX in Q4 2018 and held it in 6 quarters. The position peaked at $12.5M in Q1 2020. 1 fund tracked by Wall St. Rank holds RARX as of Q2 2020.

State of Wisconsin Investment Board reported no remaining Ra Pharmaceuticals, Inc. Common Stock position as of Q2 2020 after selling out during the quarter.
State of Wisconsin Investment Board sold 259,994 Ra Pharmaceuticals, Inc. Common Stock shares in Q2 2020, an estimated $12.5M.
State of Wisconsin Investment Board first reported a position in Ra Pharmaceuticals, Inc. Common Stock in Q4 2018 and held it in 6 quarters.
State of Wisconsin Investment Board's Ra Pharmaceuticals, Inc. Common Stock position peaked at $12.5M in Q1 2020.
1 fund tracked by Wall St. Rank held Ra Pharmaceuticals, Inc. Common Stock as of Q2 2020.

Based on State of Wisconsin Investment Board's 13F filing for Q2 2020, filed 12 Aug 2020.